Cardiovascular disease Archives

acute heart failure 4teen4 pharmaceuticals

More News! 5 Dec 2019

German Biotech Raises €7M Series A to Treat Acute Heart Failure

4TEEN4 Pharmaceuticals has raised a Series A round of €6.9M to fuel the development of a first-in-class antibody drug that could reduce mortality in acute heart failure. The round was led by Brandenburg Kapital, a subsidiary of the German investment bank Investitionsbank des Landes Brandenburg. Other investors in the round, including business angels and private […]

December 5, 2019 - 2 minutesmins - By Jonathan Smith

cardiology astrazeneca novartis cardiovascular disease

News and Trends 5 Sep 2019

Top Cardiology Biotech News from the ESC Conference 2019

Many cardiology companies and academics gathered in Paris earlier this week to showcase their latest research into cardiovascular diseases. Read on for a roundup of the most exciting cardiology news from the biotech scene. The European Society of Cardiology teamed up with the World Heart Federation this year to arrange a conference themed on global […]

September 5, 2019 - 4 minutesmins - By Jonathan Smith

anti aging cardiovascular disease centenarian gene therapy

News and Trends 10 Jul 2019

Anti-Aging Gene Therapy Treats Cardiovascular Disease in Mice

A research group in Italy has reduced cardiovascular disease in mice by expressing an anti-aging gene often seen in centenarians. This could one day lead to a gene therapy treating the same condition in humans. Centenarians have long lives thanks to a mix of their environment, lifestyle, and their genes. In the past, researchers at […]

July 10, 2019 - 3 minutesmins - By Jonathan Smith

acne s biomedic skinbiotherapeutics skin microbiome

News and Trends 2 Jul 2019

Microbiome Food Supplement Improves Metabolic Syndrome in Overweight People

A food supplement made from bacteria, developed by a Belgian research group, has improved symptoms of the metabolic syndrome including insulin resistance and high blood cholesterol levels in overweight volunteers at risk of heart disease and type 2 diabetes. The metabolic syndrome is a collection of conditions including high blood cholesterol, insulin resistance and high […]

July 2, 2019 - 3 minutesmins - By Jonathan Smith

heart disease cardiovascular disease cholesterol zora biosciences

News and Trends 24 Jun 2019

Diagnostic Test Beats ‘Bad’ Cholesterol at Predicting Heart Attacks

A study run by the Finnish diagnostics biotech Zora Biosciences has found two biomarkers that are better at predicting heart attacks and deaths in patients with coronary heart disease than the current gold standard — measuring ‘bad’ cholesterol in the blood. To assess the risk of death or heart attacks in people with coronary […]

June 24, 2019 - 2 minutesmins - By Jonathan Smith

More News! 16 Apr 2019

Researchers in Israel 3D Print a Personalized Heart from Donor’s Tissue

A group of scientists in Israel is the first to 3D print a vascularized heart using reprogrammed cells and biological material from a donor. The technology could one day provide printed hearts for transplants with low risks of rejection by a patient’s immune system. Organ bioprinting is a technique similar to 3D printing where you […]

April 16, 2019 - 3 minutesmins - By Jonathan Smith

More News! 4 Mar 2019

Swiss Biotech Raises €8.8M to Progress Regenerative Stroke Treatment

The Swiss company NovaGo has raised €8.8M (CHF 10M) in Series A funding to develop one of the first therapies to help the nervous system regenerate after a stroke. Novago develops antibodies that inhibit Nogo-A, a key molecule that stops nerve cells from growing new connections in the adult brain and spinal cord. This lets […]

March 4, 2019 - 3 minutesmins - By Jonathan Smith

novo nordisk staten fat hypertriglyceridemia cardiovascular disease

News and Trends 17 Dec 2018

Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease

Novo Nordisk and the Dutch company Staten Biotechnology will partner to develop a treatment to remove excess fatty molecules called triglycerides from the blood, high levels of which increase a person’s risk for cardiovascular disease. Novo has agreed to pay up to €430M for the worldwide rights to Staten’s candidate drug, as well as the exclusive […]

December 17, 2018 - 2 minutesmins - By Jonathan Smith

More News! 13 Nov 2018

French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins

The French company Quantum Genomics is developing a first-in-class drug that targets proteins in the brain to lower blood pressure. A Phase IIb trial, run by Quantum Genomics, found that eight weeks of taking its drug significantly lowered blood pressure in patients who were overweight or obese and with high blood pressure. This reduction also […]

November 13, 2018 - 2 minutesmins - By Jonathan Smith

News and Trends 5 Nov 2018

Series C Bags German Company €17M for Irregular Heartbeat Treatment

Omeicos Therapeutics has secured €17M in a Series C round to fund clinical development of its lead treatment for irregular heartbeat. Robert Fischer, CEO of the German biopharmaceutical company, told me that getting the attention of investors such as the Dutch company Forbion, which led the round, was just as helpful as the money itself. […]

November 5, 2018 - 2 minutesmins - By Jonathan Smith

In Depth 30 Oct 2018

Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier

What do shuttles, bubbles and ultrasound have in common? They are all methods that can all be used to target the blood–brain barrier and make treating brain diseases such as cancer and Alzheimer’s easier. The blood–brain barrier is the gatekeeper to the brain. This highly selective protective sheath regulates the flow of substances in and […]

October 30, 2018 - 7 minutesmins - By External Contributor

News and Trends 26 Sep 2018

Fish Oils Finally Reel in Positive Results for Cardiovascular Disease

Purified fish oil can reduce patients’ risks for adverse cardiovascular events by 25%, according to US-Irish Biotech Amarin’s Phase III trial results. The treatment, called Vascepa, significantly reduced the risk of strokes, heart attacks, and death. It also had a good safety profile in the over 8,000 enrolled patients, who were already taking statins. These […]

September 26, 2018 - 2 minutesmins - By Jonathan Smith

Knowledge hub

Categories

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Approaches

Therapeutic areas

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Cardiovascular disease

German Biotech Raises €7M Series A to Treat Acute Heart Failure

Top Cardiology Biotech News from the ESC Conference 2019

Anti-Aging Gene Therapy Treats Cardiovascular Disease in Mice

Microbiome Food Supplement Improves Metabolic Syndrome in Overweight People

Diagnostic Test Beats ‘Bad’ Cholesterol at Predicting Heart Attacks

Researchers in Israel 3D Print a Personalized Heart from Donor’s Tissue

Swiss Biotech Raises €8.8M to Progress Regenerative Stroke Treatment

Novo Nordisk Partners Dutch Biotech to Prevent Cardiovascular Disease

French Company’s Drug Lowers Blood Pressure by Targeting Brain Proteins

Series C Bags German Company €17M for Irregular Heartbeat Treatment

Shuttles, Bubbles and Ultrasound: Crossing the Blood–Brain Barrier

Fish Oils Finally Reel in Positive Results for Cardiovascular Disease

Subscribe to our newsletter to get the latest biotech news!

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Catalonia: A biotech hub going from strength to strength, with Barcelona at its core

Top biotech deals of February 2025

Grab your free report on 3D organoids and explore their future potential

These 7 biotechs are shaping the next generation of endometriosis care

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!